{
    "Title": "The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000â€“2007)",
    "URL": "https://doi.org/10.1371/journal.pntd.0000708",
    "Published": "June 1, 2010",
    "Subject_Areas": [
        "Health economics",
        "Lymphedema",
        "Hydrocele",
        "Economics",
        "Economic impact analysis",
        "Morbidity",
        "Socioeconomic aspects of health",
        "Global health"
    ],
    "Authors": {
        "Brian K. Chu": [
            "Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America"
        ],
        "Pamela J. Hooper": [
            "Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America"
        ],
        "Mark H. Bradley": [
            "Global Community Partnerships, GlaxoSmithKline, London, United Kingdom"
        ],
        "Deborah A. McFarland": [
            "Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America"
        ],
        "Eric A. Ottesen": [
            "Lymphatic Filariasis Support Center, The Task Force for Global Health, Decatur, Georgia, United States of America"
        ]
    }
}